Treatment completion of drug-resistant tuberculosis in Ethiopia: A perspective from healthcare users.

Drug-resistant tuberculosis remains a persistent public health threat. Maximizing successful treatment completion is a global health priority and a focus of the End TB strategy. Despite the implementation of programmatic management for drug-resistant tuberculosis in Ethiopia, there is limited unders...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmed Reshid Tusho, Sheila Theresa Mokoboto-Zwane
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLOS Global Public Health
Online Access:https://doi.org/10.1371/journal.pgph.0004110
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823856675222716416
author Ahmed Reshid Tusho
Sheila Theresa Mokoboto-Zwane
author_facet Ahmed Reshid Tusho
Sheila Theresa Mokoboto-Zwane
author_sort Ahmed Reshid Tusho
collection DOAJ
description Drug-resistant tuberculosis remains a persistent public health threat. Maximizing successful treatment completion is a global health priority and a focus of the End TB strategy. Despite the implementation of programmatic management for drug-resistant tuberculosis in Ethiopia, there is limited understanding of the barriers related to successful treatment completion among Ethiopian patients. A qualitative study that is explorative, descriptive and contextual in nature was conducted to explore and describe the views and lived experiences of previously treated drug-resistant tuberculosis patients to gain an in-depth understanding of barriers to the successful completion of drug-resistant tuberculosis treatment. Six focus group discussion sessions with 42 purposively selected drug-resistant tuberculosis patients with previous treatment history and on retreatment regimens were conducted. The seven prominent themes revealed were: drug-related challenges encompassing adverse events and the lengthy treatment duration; clinical hurdles such as delayed consultation following prolonged illness, diagnostic delays, and suboptimal dosages; psycho-emotional difficulties including emotional trauma and facing stigma from both the community and healthcare professionals; socio-economic constraints; service-related issues such as interruptions in monitoring tests, inadequate follow-up, and accessibility barriers; patient-related factors such as a false sense of recovery and reverting to previously quit habits; and provider-related issues such as lack of responsiveness and ineffective communication. Addressing these factors demands policy-level decisions and programmatic guidance at the national level based on best practices, as well as good programmatic implementation from actors through regional and health facility-level structures.
format Article
id doaj-art-82f2d3a1373649deb70109a9ace0772d
institution Kabale University
issn 2767-3375
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLOS Global Public Health
spelling doaj-art-82f2d3a1373649deb70109a9ace0772d2025-02-12T05:48:26ZengPublic Library of Science (PLoS)PLOS Global Public Health2767-33752025-01-0152e000411010.1371/journal.pgph.0004110Treatment completion of drug-resistant tuberculosis in Ethiopia: A perspective from healthcare users.Ahmed Reshid TushoSheila Theresa Mokoboto-ZwaneDrug-resistant tuberculosis remains a persistent public health threat. Maximizing successful treatment completion is a global health priority and a focus of the End TB strategy. Despite the implementation of programmatic management for drug-resistant tuberculosis in Ethiopia, there is limited understanding of the barriers related to successful treatment completion among Ethiopian patients. A qualitative study that is explorative, descriptive and contextual in nature was conducted to explore and describe the views and lived experiences of previously treated drug-resistant tuberculosis patients to gain an in-depth understanding of barriers to the successful completion of drug-resistant tuberculosis treatment. Six focus group discussion sessions with 42 purposively selected drug-resistant tuberculosis patients with previous treatment history and on retreatment regimens were conducted. The seven prominent themes revealed were: drug-related challenges encompassing adverse events and the lengthy treatment duration; clinical hurdles such as delayed consultation following prolonged illness, diagnostic delays, and suboptimal dosages; psycho-emotional difficulties including emotional trauma and facing stigma from both the community and healthcare professionals; socio-economic constraints; service-related issues such as interruptions in monitoring tests, inadequate follow-up, and accessibility barriers; patient-related factors such as a false sense of recovery and reverting to previously quit habits; and provider-related issues such as lack of responsiveness and ineffective communication. Addressing these factors demands policy-level decisions and programmatic guidance at the national level based on best practices, as well as good programmatic implementation from actors through regional and health facility-level structures.https://doi.org/10.1371/journal.pgph.0004110
spellingShingle Ahmed Reshid Tusho
Sheila Theresa Mokoboto-Zwane
Treatment completion of drug-resistant tuberculosis in Ethiopia: A perspective from healthcare users.
PLOS Global Public Health
title Treatment completion of drug-resistant tuberculosis in Ethiopia: A perspective from healthcare users.
title_full Treatment completion of drug-resistant tuberculosis in Ethiopia: A perspective from healthcare users.
title_fullStr Treatment completion of drug-resistant tuberculosis in Ethiopia: A perspective from healthcare users.
title_full_unstemmed Treatment completion of drug-resistant tuberculosis in Ethiopia: A perspective from healthcare users.
title_short Treatment completion of drug-resistant tuberculosis in Ethiopia: A perspective from healthcare users.
title_sort treatment completion of drug resistant tuberculosis in ethiopia a perspective from healthcare users
url https://doi.org/10.1371/journal.pgph.0004110
work_keys_str_mv AT ahmedreshidtusho treatmentcompletionofdrugresistanttuberculosisinethiopiaaperspectivefromhealthcareusers
AT sheilatheresamokobotozwane treatmentcompletionofdrugresistanttuberculosisinethiopiaaperspectivefromhealthcareusers